BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 33430887)

  • 1. Pancreatic ductal adenocarcinoma and distal cholangiocarcinoma: a proposal of preoperative diagnostic score for differential diagnosis.
    Muttillo EM; Ciardi A; Troiano R; Saullo P; Masselli G; Guida M; Tortora A; Sperduti I; Marinello G; Chirletti P; Caronna R
    World J Surg Oncol; 2021 Jan; 19(1):10. PubMed ID: 33430887
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A Prognostic Score for Predicting Survival in Patients With Pancreatic Head Adenocarcinoma and Distal Cholangiocarcinoma.
    Muttillo EM; Ciardi A; Saullo P; Troiano R; Masselli G; Guida M; Tortora A; Sperduti I; Marinello G; Chirletti P; Caronna R
    In Vivo; 2021; 35(1):507-515. PubMed ID: 33402503
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Intra-pancreatic distal cholangiocarcinoma and pancreatic ductal adenocarcinoma: a common short and long-term prognosis?
    Guilbaud T; Girard E; Lemoine C; Schlienger G; Alao O; Risse O; Berdah S; Chirica M; Moutardier V; Birnbaum DJ
    Updates Surg; 2021 Apr; 73(2):439-450. PubMed ID: 33486711
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Tumour origin, diagnostic accuracy and histopathological evaluation in patients with periampullary cancer: nationwide cohort study.
    Byrling J; Ghazi S; Andersson B
    BJS Open; 2023 Sep; 7(5):. PubMed ID: 37864577
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Distal Cholangiocarcinoma and Pancreas Adenocarcinoma: Are They Really the Same Disease? A 13-Institution Study from the US Extrahepatic Biliary Malignancy Consortium and the Central Pancreas Consortium.
    Ethun CG; Lopez-Aguiar AG; Pawlik TM; Poultsides G; Idrees K; Fields RC; Weber SM; Cho C; Martin RC; Scoggins CR; Shen P; Schmidt C; Hatzaras I; Bentrem D; Ahmad S; Abbott D; Kim HJ; Merchant N; Staley CA; Kooby DA; Maithel SK
    J Am Coll Surg; 2017 Apr; 224(4):406-413. PubMed ID: 28017812
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Celiac axis occlusion of a patient undergoing pancreaticoduodenectomy after distal gastrectomy.
    Nakano H; Yamamura T; Yamaguchi S; Otsubo T
    Hepatogastroenterology; 2007 Mar; 54(74):595-8. PubMed ID: 17523329
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The morbidity, mortality, and prognostic factors for ampullary carcinoma and distal cholangiocarcinoma.
    Shimizu Y; Kimura F; Shimizu H; Yoshidome H; Ohtsuka M; Miyazaki M
    Hepatogastroenterology; 2008; 55(82-83):699-703. PubMed ID: 18613437
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Infiltration of peritumoural but tumour-free parenchyma with IgG4-positive plasma cells in hilar cholangiocarcinoma and pancreatic adenocarcinoma.
    Resheq YJ; Quaas A; von Renteln D; Schramm C; Lohse AW; Lüth S
    Dig Liver Dis; 2013 Oct; 45(10):859-65. PubMed ID: 23602806
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Preoperative misdiagnosis of pancreatic and periampullary cancer in patients undergoing pancreatoduodenectomy: A multicentre retrospective cohort study.
    van Roessel S; Soer EC; Daamen LA; van Dalen D; Fariña Sarasqueta A; Stommel MWJ; Molenaar IQ; van Santvoort HC; van de Vlasakker VCJ; de Hingh IHJT; Groen JV; Mieog JSD; van Dam JL; van Eijck CHJ; van Tienhoven G; Klümpen HJ; Wilmink JW; Busch OR; Brosens LAA; Groot Koerkamp B; Verheij J; Besselink MG;
    Eur J Surg Oncol; 2021 Oct; 47(10):2525-2532. PubMed ID: 33745791
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A differential microRNA profile distinguishes cholangiocarcinoma from pancreatic adenocarcinoma.
    Collins AL; Wojcik S; Liu J; Frankel WL; Alder H; Yu L; Schmittgen TD; Croce CM; Bloomston M
    Ann Surg Oncol; 2014 Jan; 21(1):133-8. PubMed ID: 24046106
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Transpapillary biliary biopsy for malignant biliary strictures: comparison between cholangiocarcinoma and pancreatic cancer.
    Chen WM; Wei KL; Chen YS; Chang PJ; Tung SY; Chang TS; Huang HC; Shen CH; Hsieh YY; Wu CS
    World J Surg Oncol; 2016 May; 14():140. PubMed ID: 27142076
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pancreaticoduodenectomy for periampullary carcinoma.
    Wagle PK; Joshi RM; Mathur SK
    Indian J Gastroenterol; 2001; 20(2):53-5. PubMed ID: 11305490
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Major Postoperative Complications Limit Adjuvant Therapy Administration in Patients Undergoing Pancreatoduodenectomy for Distal Cholangiocarcinoma or Pancreatic Ductal Adenocarcinoma.
    Macfie R; Berger Y; Liu H; Li T; Imtiaz S; Ang C; Sarpel U; Hiotis S; Labow D; Golas B; Cohen NA
    Ann Surg Oncol; 2023 Aug; 30(8):5027-5034. PubMed ID: 37210446
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prognostic indicators following curative pancreatoduodenectomy for pancreatic carcinoma: A retrospective multivariate analysis of a single centre experience.
    Petrou A; Soonawalla Z; Silva MA; Manzelli A; Moris D; Tabet PP; Friend P
    J BUON; 2016; 21(4):874-882. PubMed ID: 27685908
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The novel monoclonal antibody HPC2 and N-cadherin distinguish pancreatic ductal adenocarcinoma from cholangiocarcinoma.
    Hooper JE; Morgan TK; Grompe M; Sheppard BC; Troxell ML; Corless CL; Streeter PR
    Hum Pathol; 2012 Oct; 43(10):1583-9. PubMed ID: 22406361
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Surgical treatment of distal cholangiocarcinoma].
    Bahra M
    Chirurg; 2021 Sep; 92(9):788-795. PubMed ID: 34232340
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Robotic approach mitigates the effect of major complications on survival after pancreaticoduodenectomy for periampullary cancer.
    Meyyappan T; Wilson GC; Zeh HJ; Hogg ME; Lee KK; Zureikat AH; Paniccia A
    Surg Endosc; 2023 Feb; 37(2):1181-1187. PubMed ID: 36163566
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Thrombospondin-2 as a diagnostic biomarker for distal cholangiocarcinoma and pancreatic ductal adenocarcinoma.
    Byrling J; Hilmersson KS; Ansari D; Andersson R; Andersson B
    Clin Transl Oncol; 2022 Feb; 24(2):297-304. PubMed ID: 34319497
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Factors influencing postoperative morbidity, mortality, and survival after resection for hilar cholangiocarcinoma.
    Su CH; Tsay SH; Wu CC; Shyr YM; King KL; Lee CH; Lui WY; Liu TJ; P'eng FK
    Ann Surg; 1996 Apr; 223(4):384-94. PubMed ID: 8633917
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Surgical management of cholangiocarcinoma.
    Jarnagin WR; Shoup M
    Semin Liver Dis; 2004 May; 24(2):189-99. PubMed ID: 15192791
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.